Fetal Hypoglycemia Induced by Placental SLC2A3-RNA Interference Alters Fetal Pancreas Development and Transcriptome at Mid-Gestation
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25094780 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Victoria C Kennedy und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Colorado State University, Fort Collins, CO 80523, USA. Hauptthemen laut MEDLINE: Placenta, Pancreas, Hypoglycemia, Transcriptome. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Health, NICHD NIH HHS, United States Department of Agriculture.
Abstract (Originalsprache)
Glucose, the primary energy substrate for fetal oxidative processes and growth, is transferred from maternal to fetal circulation down a concentration gradient by placental facilitative glucose transporters. In sheep, SLC2A1 and SLC2A3 are the primary transporters available in the placental epithelium, with SLC2A3 located on the maternal-facing apical trophoblast membrane and SLC2A1 located on the fetal-facing basolateral trophoblast membrane. We have previously reported that impaired placental SLC2A3 glucose transport resulted in smaller, hypoglycemic fetuses with reduced umbilical artery insulin and glucagon concentrations, in addition to diminished pancreas weights. These findings led us to subject RNA derived from SLC2A3-RNAi (RNA interference) and NTS-RNAi (non-targeting sequence) fetal pancreases to qPCR followed by transcriptomic analysis. We identified a total of 771 differentially expressed genes (DEGs). Upregulated pathways were associated with fat digestion and absorption, particularly fatty acid transport, lipid metabolism, and cholesterol biosynthesis, suggesting a potential switch in energetic substrates due to hypoglycemia. Pathways related to molecular transport and cell signaling in addition to pathways influencing growth and metabolism of the developing pancreas were also impacted. A few genes directly related to gluconeogenesis were also differentially expressed. Our results suggest that fetal hypoglycemia during the first half of gestation impacts fetal pancreas development and function that is not limited to β cell activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Colorado State University, Fort Collins, CO 80523, USA.
- University of Colorado School of Medicine, Aurora, CO 80045, USA.
ORCID-Profile: Victoria C Kennedy, Ahmed Gad, Russell V Anthony
Förderung
- National Institute of Health
- NICHD NIH HHS
- United States Department of Agriculture
- National Institutes of Health grants
Zitieren
APA
Kennedy, V. C., Lynch, C. S., Tanner, A. R., Winger, Q. A., Gad, A., Rozance, P. J., & Anthony, R. V. (2024). Fetal Hypoglycemia Induced by Placental SLC2A3-RNA Interference Alters Fetal Pancreas Development and Transcriptome at Mid-Gestation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25094780
Vancouver
Kennedy VC, Lynch CS, Tanner AR, Winger QA, Gad A, Rozance PJ, et al. Fetal Hypoglycemia Induced by Placental SLC2A3-RNA Interference Alters Fetal Pancreas Development and Transcriptome at Mid-Gestation. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25094780
BibTeX
@article{Kennedy2024,
author = {Kennedy, Victoria C and Lynch, Cameron S and Tanner, Amelia R and Winger, Quinton A and Gad, Ahmed and Rozance, Paul J and Anthony, Russell V},
title = {Fetal Hypoglycemia Induced by Placental SLC2A3-RNA Interference Alters Fetal Pancreas Development and Transcriptome at Mid-Gestation},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25094780}
}
EUVIMED